ATE198418T1 - Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz - Google Patents

Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz

Info

Publication number
ATE198418T1
ATE198418T1 AT94927028T AT94927028T ATE198418T1 AT E198418 T1 ATE198418 T1 AT E198418T1 AT 94927028 T AT94927028 T AT 94927028T AT 94927028 T AT94927028 T AT 94927028T AT E198418 T1 ATE198418 T1 AT E198418T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
regeneration
tissue healing
promoting tissue
biocompatible carrier
Prior art date
Application number
AT94927028T
Other languages
English (en)
Inventor
Maurizio Dr Tonetti
Original Assignee
Maurizio Dr Tonetti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maurizio Dr Tonetti filed Critical Maurizio Dr Tonetti
Application granted granted Critical
Publication of ATE198418T1 publication Critical patent/ATE198418T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
    • A61K6/69—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT94927028T 1993-10-04 1994-09-30 Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz ATE198418T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13095893A 1993-10-04 1993-10-04
PCT/IB1994/000300 WO1995009607A1 (en) 1993-10-04 1994-09-30 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it

Publications (1)

Publication Number Publication Date
ATE198418T1 true ATE198418T1 (de) 2001-01-15

Family

ID=22447200

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94927028T ATE198418T1 (de) 1993-10-04 1994-09-30 Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz

Country Status (8)

Country Link
US (1) US5795592A (de)
EP (1) EP0722312B1 (de)
JP (1) JPH09507212A (de)
CN (1) CN1056973C (de)
AT (1) ATE198418T1 (de)
CA (1) CA2173111A1 (de)
DE (1) DE69426530D1 (de)
WO (1) WO1995009607A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455064B1 (en) 1998-04-30 2002-09-24 Closure Medical Corporation Method of applying an adhesive composition over a bioactive polymerization initiator or accelerator
EP1073468A1 (de) * 1998-04-30 2001-02-07 Closure Medical Corporation Verwendung einer klebrigen zusammensetzung mit einem bioaktiven polymerisierungsinitiator oder-beschleuniger
US6579469B1 (en) 1999-10-29 2003-06-17 Closure Medical Corporation Cyanoacrylate solutions containing preservatives
US6402518B1 (en) * 1999-11-30 2002-06-11 Arthur Ashman Method and apparatus for performing ridge augmentation
US6692526B1 (en) * 2000-03-15 2004-02-17 Michael E. Snyder Ophthalmological surgery colorant and delivery system
WO2002015882A1 (en) * 2000-08-24 2002-02-28 Lytone Enterprise, Inc. Delayed release compositions and combinations
US20040147534A1 (en) * 2003-01-23 2004-07-29 Foote Mary Ann Topical composition and method for treating occlusive wounds
WO2007073264A1 (en) * 2005-12-22 2007-06-28 Sca Hygiene Products Ab Absorbent article
DE102006033167A1 (de) 2006-07-10 2008-01-24 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung eines vernetzenden medizinischen Klebers
DE102006033168A1 (de) 2006-07-10 2008-01-17 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung einer vernetzenden therapeutischen Zusammensetzung
WO2009023122A1 (en) * 2007-08-10 2009-02-19 Ariston Pharmaceuticals, Inc. Cobalamin regimens for the treatment of nitrogen oxide-mediated conditions
DE102008062373A1 (de) * 2007-12-21 2009-06-25 Essiger, Holger, Dr. Mittel, mit mindestens einem Wirkstoff, der eine Zahnfleischwachstumswirkung aufweist
US10570390B2 (en) 2011-08-19 2020-02-25 Rodney J. Y. Ho Compositions, devices, and methods for treating infections

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4175326A (en) * 1977-10-26 1979-11-27 Forsyth Dental Infirmary For Children Hollow-fiber devices for and a method of the treament and diagnosis of oral diseases
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4454110A (en) * 1982-05-24 1984-06-12 Forsyth Dental Infirmary For Children Self-gelling liquid composition for topical application in the oral cavity
JPS59196814A (ja) * 1983-04-21 1984-11-08 Nippon Kayaku Co Ltd シ−ト状ニフエジピン製剤
JPS59222406A (ja) * 1983-06-01 1984-12-14 Teijin Ltd 歯周疾患治療用製剤及びその製造法
US4685883A (en) * 1983-09-12 1987-08-11 Jernberg Gary R Local delivery of chemotherapeutic agents for the treatment of periodontal disease
US4764377A (en) * 1983-10-07 1988-08-16 The Forsyth Dental Infirmary For Children Intra-pocket drug delivery devices for treatment of periodontal diseases
FR2591892B1 (fr) * 1985-12-23 1988-09-16 Pf Medicament Association collagene/principe actifantiseptique et/ou anti-inflammatoire a titre de composition, son procede de preparation et son utilisation pour la fabrication d'une composition pharmaceutique
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
JPH01238543A (ja) * 1988-03-16 1989-09-22 Shiseido Co Ltd 口腔用組成物
US5290552A (en) * 1988-05-02 1994-03-01 Matrix Pharmaceutical, Inc./Project Hear Surgical adhesive material
EP0341007B1 (de) * 1988-05-02 1994-09-14 Project Hear Chirurgisches Klebstoffmaterial
US5047244A (en) * 1988-06-03 1991-09-10 Watson Laboratories, Inc. Mucoadhesive carrier for delivery of therapeutical agent
US5075115A (en) * 1990-04-02 1991-12-24 Fmc Corporation Process for polymerizing poly(lactic acid)
US5130121A (en) * 1990-04-17 1992-07-14 Isp Investments Inc. Skin care compositions containing discrete microdroplets of an oil in water stabilized by in situ polymerization of water-soluble vinyl monomer
US5059123A (en) * 1990-05-14 1991-10-22 Jernberg Gary R Periodontal barrier and method for aiding periodontal tissue regeneration
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5266326A (en) * 1992-06-30 1993-11-30 Pfizer Hospital Products Group, Inc. In situ modification of alginate

Also Published As

Publication number Publication date
CN1134107A (zh) 1996-10-23
CN1056973C (zh) 2000-10-04
CA2173111A1 (en) 1995-04-13
EP0722312B1 (de) 2001-01-03
US5795592A (en) 1998-08-18
EP0722312A1 (de) 1996-07-24
WO1995009607A1 (en) 1995-04-13
JPH09507212A (ja) 1997-07-22
DE69426530D1 (de) 2001-02-08

Similar Documents

Publication Publication Date Title
HUP0102899A2 (hu) Eljárás gyulladásgátló, különösen fertőtlenítő hatású és/vagy sebgyógyulást elősegítő szerek alsó légutakba történő beadására szolgáló készítmények előállítására
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
DK1140212T3 (da) Målrettet anvendelse af radium 223 mod kalkholdigt væv til lettelse af smerter ved behandling af knoglekræft
DK0862416T3 (da) Ikke-polymert indgivelsessystem med forhalet frigørelse
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
DE69813908D1 (de) Verwendung von kreatinsubstanzen zur behandlung von knochen- und knorpelzellen und geweben
ATE198418T1 (de) Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
CA2184916A1 (en) Use of fibroblast growth factors to stimulate bone growth
DE60112777D1 (de) Beschichtete medizinische geräte und verfahren zur sterilisation
ATE162073T1 (de) Pharmazeutische zusammensetzung zur behandlung von osteoporose enthaltend xanthohumol
WO2001041753A3 (en) Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds
BR0010531A (pt) Composições e usos de et743 para tratamento de câncer
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
PT1069902E (pt) Utilizacao de fosfolipidos na producao de um medicamento para a prevencao de adesoes
RU94037986A (ru) Материал для восстановления костной ткани
BRPI0407178A (pt) Composição farmacêutica osteogênica
GB2331926A (en) Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
ATE458471T1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea
KR930021178A (ko) 뼈 형성을 자극하는 약제
KR960003741A (ko) 조골세포 증식인자
BR0016646A (pt) Método para tratar um paciente que sofre de dor, e, composição farmacêutica
RU2175863C1 (ru) Способ лечения хронического пародонтита
DE68901018D1 (de) Arzneimittel zur regulierung der hormonellen sekretionen und zur behandlung der weiblichen sterilitaet.
UA43800A (uk) Спосіб лікування перфоративної виразки дванадцятипалої кишки

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties